Related Experiment Videos
[Spontaneous tumor regression. Report of 2 cases]
M Sureda1, M L Subirá, S Martín Algarra
1Departamento de Oncología, Clínica Universitaria de Navarra, Pamplona.
Medicina Clinica
|September 15, 1990
Summary
Spontaneous tumor regression (STR) was observed in non-Hodgkin lymphoma and lung squamous carcinoma. Immunological mechanisms, including cytotoxic cells and cytokine production, may drive this rare phenomenon.
Area of Science:
- Oncology
- Immunology
Background:
- Spontaneous tumor regression (STR) is a rare phenomenon where tumors decrease in size or disappear without specific treatment.
- Understanding the mechanisms behind STR is crucial for developing novel cancer therapies.
Observation:
- Two cases of STR are presented: one in a patient with non-Hodgkin lymphoma and another with squamous carcinoma of the lung.
- Both cases met the established criteria for STR, as defined by Everson and Cole.
Findings:
- Emerging research suggests immunological mechanisms are key mediators of STR.
- Potential mechanisms include the generation of antineoplastic cytotoxic cells, production of immunoregulatory cytokines by immune cells (lymphocytes and monocytes), and cross-reactivity between tumor and bacterial antigens.
Implications:
- These findings highlight the potential of harnessing the immune system for cancer treatment.
- Further investigation into these immunological pathways could lead to new therapeutic strategies for various cancers, including lymphoma and lung carcinoma.